Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
life sciences
national blog main
national top stories
new york blog main
san diego blog main
san diego top stories
3
×
san francisco blog main
biogen
biotech
boulder/denver blog main
boulder/denver top stories
cancer
deals
detroit blog main
detroit top stories
eli lilly
fda
indiana blog main
indiana top stories
ipo
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
abbvie
akouos
alex azar
allergan
alliance for aging research
alnylam pharmaceuticals
What
plans
3
×
ipo
acquisitions
administration
advance
angry
announced
anti
benefited
bio
biology
ceo
collabs
company
covid
cytokine
daniel
deal
despite
drug
drugs
enhanced
fear
files
gilead
gilead’s
help
industry
initial
introduce
laying
losing
medicines
money
month
offering
o’day
pharma
presidential
price
Language
unset
Current search:
plans
×
" san diego top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs